Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks
I didn't get to listen in to the call.
You mentioned "Higher Share price was mentioned as a solution"...
Do you think they are referring to an R/S as a means to boost share price?
I think if they have higher revenue from Belfrics, the next 10-Q should show higher revenue and growth would should bump the SP.
Higher share price via R/S will kill this.
Shout Out to Dragon Lady
It started out all positive over three years ago and I ignored all the red flags I saw trying to stay positive. I had over $70K in CELZ before the prior R/S. After that R/S I decided I would let my money sit. Maybe Tim could pull his head out. I even dumped in a couple more grand to lower my average. Now another R/S!
PLEASE QUIT DONATING YOUR MONEY to THESE GUYS!
Most have bashed Dragon Lady because the truth was being told. Dragon Lady was right on just about everything over the past few years!
Shittiest Company I Ever Invested in!
8K is out!
500 / 1
They could have easily hit $.01+ with another PR and better communication.
In this case, an R/S is the wrong way to raise share price. Seems to me they have other intentions and hopefully it's not just dilution.
At work so not sure of exact date yet but we will be luck to hit 3 cents by the time it goes through.
If we don't get good news to back it, below a penny it goes
11,000,000 to 733,333 SUCKS!
First they mislead investors previously stating "No Reverse Split".
They have a tiny market cap and little revenue.
R/S rarely ever benefit shareholders.
They better have huge news coming after the split and not another stinking phone app or this will tank below a penny again after the R/S.
Wuling Motors Posts Record Sales in First 2 Months of 2021
NANNING, March 14 (Xinhua) -- SAIC-GM-Wuling (SGMW), a major Chinese automobile manufacturer, reported strong new energy vehicle (NEV) sales in the first two months of 2021, the company has said.
SGMW, a joint venture between SAIC Motor, General Motors, and Liuzhou Wuling Motors, registered record NEV sales of 59,315 units in the January-February period.
SGMW produces NEV models including the Hongguang MINI EV, the new Baojun E300, the Baojun E100, and the Baojun E200.
The Hongguang MINI EV achieved robust sales of more than 36,000 units in January. As of March 4, total sales of the model have exceeded 200,000 units since it was launched 200 days ago, according to the company.
SOURCE: http://www.xinhuanet.com/english/2021-03/14/c_139809045.htm
Wuling Journey Pickup Truck Goes On Sale in March
GM's Chinese brand, SAIC-GM-Wuling. The all-new Wuling Journey pickup is scheduled to go on sale in the Chinese market in March.
https://gmauthority.com/blog/2021/02/all-new-wuling-journey-pickup-interior-design-revealed/
Wuling Motors #2 behind Tesla in China’s 2020 Best-Selling Top 10
The Chinese Hongguang Mini which is jointly developed by General Motors with Wuling Motors and stated-owned SAIC Motor outperformed the famous Tesla as the best-selling new energy vehicle in December and second-best for the year.
https://www.chinaknowledge.com/News/DetailNews/91165/
RSAMMD Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
https://www.newsfilecorp.com/release/55519/Republic-of-South-Africa-Medical-Marijuana-Dispensaries-RSAMMD-Announces-Successful-Testing-Results-of-Proprietary-Cannabis-Plant-Extraction-Technology-with-JV-Partner-Protex-Pharma-TXTM
Live Cannabis Plant Extraction into Highly Bioavailable, Non-psychoactive Cannabis Medicines Now Possible
Johannesburg, South Africa--(Newsfile Corp. - May 7, 2020) - Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce the successful testing of its proprietary live cannabis plant extraction technology in conjunction with its joint venture partner, US-based Protext Pharma, Inc. (OTC Pink: TXTM). The testing took place over several days during the last couple months and involved various extract samples being produced under different conditions including water temperature and then tested for chemical composition. Independent third-party lab testing of the samples was done at a SAHPRA licensed facility.
Mr. Dylon Du Plooy, Chief Executive Officer of RSAMMD commented, "We are happy to report the positive testing results from our extraction of live cannabis plants using Protext's proprietary extraction technology. The benefits of this extract cannot be overstated. As part of our investigations, various tests were completed using live cannabis flower and leaf, rendered into liquid emulsions. Prior to now, it was hypothecated that processing live cannabis under lower temperatures would yield a rich nano-emulsion of phytocannabinoids while retaining the non-psychoactive precursor acid form (THC-A). Through conducting multiple tests, we were able to identify an optimal temperature of water running through the Kettle. At this particular temperature we were able to produce a cannabis emulsion that tested out having a high THC-A and a low THC level below the .1% legal limit for South Africa and well below the .3% limit for the United States. Our investigations have conclusively demonstrated that full-spectrum cannabinoids can be extracted using our proprietary Kettle system, with minimal metabolic conversion, paving the way for advancement of medical research using non-psychoactive cannabis. It's also important to note that through our investigations we were also able to ascertain an optimal temperature that converts all the THC-A into THC. This may be of significant interest to those patients around the world desiring a THC medicinal product that potentially remains active in the system for a much longer period of time as well as having significantly boosted bioavailability. The same should hold true for our developing a full spectrum hemp extract containing 100+ cannabinoids found in the plant, including CDB-A, CBG-A, THC-A to name a few."
Mr. Du Plooy added, "Further, prior research and clinical trials have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract. This means that our cannabis extract should be significantly more potent while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants. Medically, this opens the door to a line of natural pharmaceuticals derived from cannabis but at a fraction of the price and with potentially superior outcomes."
"With this important milestone achieved, and the technology now proven for the application of processing live cannabis plant, we are now readying the next phase of our commercialization plans which includes developing a self-contained, modular extraction system to take the live plant extract into a final capsule form for the global market and licensing opportunities. By devising a way to extract the phytocannabinoids without metabolic conversion of THC-A, we can retain the entourage effect and the full medical potential of cannabis, but without the psychoactive property delivered by THC. We believe what we have now shown is a scientifically important milestone and a technology breakthrough that has global significance and we look forward to taking this to commercialization," concluded Mr. Du Plooy."
Worth Holding to See What Comes Next
Who knows what their plan will be but the stock will get a bump when news is released.
Could be a new path to anything...
AI
Lithium
Pot
Stem Cells
These companies go after what's hot or what they expect to be hot.
TSOI: Phase 3 Clinical Stage Biotech Company
Just a couple notes... Not sure if this made the TSOI Ihub forum or not today but Tim Dixon posted the following this morning...
--------------------------------------------------------------------
"As of today we became a Phase 3 Clinical Stage Biotech company everybody - celebrate - throw confetti - crack some champagne - eat an orange - we've made it to the promise land and now we can compete. Thanks to everyone in helping us get here - now lets take this where it needs to go to be a true Phase 3 Clinical Stage Biotech and paint it black."
--------------------------------------------------------------------
Second, I saw a post about the large O/S. I too used to shy away from stocks with anything approaching or over 1B O/S.
I have now changed the way I handle these high float stocks and it has paid off over the past week and a half!
Tim Dixon has stated there will be NO R/S under his watch.
On the other high O/S stocks I recently picked up, some of which are near 5B, just do your DD and read through their filings over the past year and make sure none have the dreaded R/S mentioned.
Investigational New Drug Application
"We are in the process of developing responses to our last interaction with the FDA regarding StemVacs cell therapy" said Timothy Dixon, President and CEO of the Company. "By leveraging our scientific colleagues and finding that StemVacs exosomes are effective in glioma, we are evaluating the possibility of applying for another Investigational New Drug application using exosomes."
FDA DEFINITION:
An Investigational New Drug Application (IND) is a request for authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans. Such authorization must be secured prior to interstate shipment and administration of any new drug or biological product that is not the subject of an approved New Drug Application or Biologics/Product License Application.
WULING MOTORS SNIPETS
FROM autonews.com
SAIC-GM-Wuling Automobile, General Motors’ light-vehicle joint venture with SAIC Motor Corp., will launch its first pickup in March, 2021
SAIC-GM-Wuling, based in the southwest China city of Liuzhou, mainly builds minibuses for the Wuling brand and entry-level cars for the Baojun marque.
Wuling’s sales grew 8.8 percent to approach 1.1 million in 2020
China's new-vehicle sales will grow 4 percent to more than 26 million in 2021. Car and light-truck deliveries are forecast to rise 7.5 percent to 21.7 million.
Launched in July, GM’s tiny Wuling Mini EV has already become China’s best selling electric vehicle, knocking Tesla’s Model 3 sedan off its perch.
GM's Wuling Venture Readies First Pickup Truck
https://www.autonews.com/china/gms-wuling-venture-readies-first-pickup
Wuling’s 2020 sales grew 8.8 percent to approach 1.1 million while Baojun deliveries slumped 34 percent to around 402,000.
Spurred by massive infrastructure projects Beijing rolled out in response to the coronavirus outbreak, China’s pickup segment bucked the overall market decline in 2020, rising 8.6 percent to some 491,000, according to the China Association of Automobile Manufacturers.
Had to Tap Out
Yesterday I was willing to hang for the long run.
BUT, with today's PR and the mention of uplisting to the NASDAQ and meeting the requirements, I'm out.
IMO, that usually means they are going to announce an R/S soon so the minimum share price meets NASDAQ requirements.
I hope so.
I found it 10 days ago and find it odd it's so cheap.
You would think out-selling Tesla in China is big news
Wuling has Joint Venture with GM
GM-Wuling tiny car overtakes Tesla to lead China's EV market
Wuling Motors won the "2020 Golden Hong Kong Stocks Best Automobile Company" award.
202 1 Nian 1 Yue 6 days, "Kim Kong stocks fifth annual awards ceremony" held in Shenzhen, Wuling Automobile ( HK305 ) from over 1000 stand at home Hong Kong stocks listed companies, was the fifth " Best Car Company " award, harvest Highly popular attention.
"The Fifth Golden Hong Kong Stocks Annual Awards Ceremony " is co-sponsored by Zhitong Finance and Tonghuashun Finance, a leading domestic Hong Kong and US stock information platform. The professional financial roadshow live platform " Big Roadshow " provides full roadshow support.
The " Best Automobile Company " aims to commend a Hong Kong-listed automobile manufacturing company that has a healthy corporate governance structure, a prominent position in the industry, and a good main business that can provide investors with continuous and stable value returns.
After being awarded the " Most Valuable Automobile and Industrial Manufacturing Company " award last year, Wuling Automobile has again won the fifth " Golden Hong Kong Stocks Best Automobile Company Award " this year. This is an affirmation of Wuling Automobile's contribution to the development of the automobile industry. It highlights the industry and investors' recognition of Wuling Motors' 2020 value investment.
As a domestic auto manufacturer with an independent brand, Wuling Motors has been focusing on the manufacturing and sales of auto parts, engines and special vehicles for many years. It is the Group's business development goal to seize major business opportunities in the rapidly growing global auto industry chain. Following the 30 years of vehicle manufacturing experience in Wuling, the Group has concentrated on researching core technologies for new energy vehicles, and has provided high-value parts and components to nearly 20 domestic and foreign OEMs, as well as providing high-quality and applicable vehicles and travel services to over one million users. Automotive Components Group has over 200 million sets, automobile engine 80 million units, special vehicles 10 million units annual production capacity management, has formed Liuzhou, Qingdao, Chongqing, Guiyang and other north-south linkage of four major production bases, and in Indonesia, India has established two overseas parts manufacturing bases. It is a national scientific and technological innovation demonstration enterprise, a national "863" project undertaking unit, and a 100 billion yuan industry Guangxi auto parts research and development center. It is also one of the few domestic Chinese local manufacturers that have entered the global top 100 auto parts powerhouses.
Wuling Motors insists on taking innovation as the core and continuously innovating products for the needs of the people. In recent years, the group has closely followed the development trend of new energy vehicles and is committed to providing customers with diversified and practical new energy vehicle productivity tools. Wuling Automobile has not only mastered the core technologies of motor drive technology, hybrid technology, vehicle control technology, and new energy vehicle integration during the development of new energy vehicles, but also mastered the " super high-strength steel pipe hot air bulge forming process and key common technologies. ” , Took the lead in developing and building the first ultra-high-strength tube hot-air bulge forming equipment and production line with independent intellectual property rights in China, which has solved the problems of new energy vehicle lightweight and safety regulations in side collisions, and helped major customers The production and sales of energy vehicles increased significantly.
Standing under the general trend of electrification, Wuling Motors has adopted a development attitude of focusing on R&D, refined operations, and win-win cooperation. In 2020 , it also launched a number of new energy logistics vehicles, wing-open vans ( " ground stall vehicles " ), and New products such as human-driven vehicles are launched, actively capturing the business opportunities of next-generation new energy vehicles, and are committed to continuously providing high-quality, efficient, and low-carbon transportation solutions for thousands of Wuling Motors customers.
202 1 Nian , Wuling Automobile at the same time stick to the main industry, will continue to promote new energy vehicles, new product innovation and upgrading, expanding and building a business ecosystem and new energy vehicle industry chain , and improve corporate value.
Rinse and Repeat
This is somewhat of same scenario as just over a year ago.
All the patents mean nothing when you aren't generating enough revenue to keep the boat afloat.
Things may appear all rosy right now with a couple PR's that sound promising but watch out for their "We plan to uplist" PR in 2021.
TRANSLATION for "We plan to uplist" is "We are planning another reverse split to meet the required minimum share price to uplist".
I Feel So Much Better Now
It's only 98% loss since the R/S.
I'm only down $77,000.00 now.
E-Trade Should Update Dec 28th - 29th
RESPONSE FROM E-TRADE
*************************************************************************
Thank you for your message regarding the ETHE stock split.
ETHE is an OTC Market stock with a 100% requirement and E*TRADE will not place the due bills split adjusted shares in the account until received. The forward split is due-bill so shares are not anticipated to be delivered until after Monday next week.
The cost basis will adjusted after the new shares are delivered.
*************************************************************************
Want Clarification - Your Thoughts?
On the recent Shareholder Update of 12/21/20
In their SUMMARY, they said
"potential uplisting to the NASDAQ market without unacceptable dilution:".
Usually, an uplisting to the NASDAQ would require a dreaded R/S.
However, they did say "without unacceptable dilution".
I say don't put the cart before the horse. Don't rush the uplist yet. Let see what trial results/updates do for the share price.
Ziverdo on the Market in India
Ziverdo Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. It is currently indicated in the first line treatment for COVID-19 positive patients.
Treats COVID Positive people for about $2.00 USD
Quadruple Therapy with Ivermectin is effective in treating COVID-19
Referring to a pre-official release of a randomized controlled trial using Ivermectin in three doses in primary contacts of COVID-19, It is said that 93 % of primary contacts who received Ivermectin did not develop any symptoms and 58 % of primary contacts who did not receive Ivermectin did progress to have symptoms of the pandemic.
“Quadruple Therapy includes Ivermectin 12 mg one dose, Doxycycline 100 mg once a day for four days, Zinc 50 mg once a day for four days and Vitamin D3 once a week. Ivermectin, Doxycycline and Zinc are to be repeated every 14 days and Vitamin D3 every week with blood levels monitored. The synergistic effect of these medicine acts to prevent viral multiplication and also stop the virus from entering human cells. Thomas Borody, an Australian gastroenterologist who is known for curing peptic ulcers with triple antibiotic therapy, has revealed that one block in South America that received Ivermectin combination prophylaxis did not contract coronavirus infection while others did,” he said.
https://www.rxindia.com/medicines/medicines-by-therapeutic-class/covid-19/ziverdo-kit/
We had No Revenues in Q3 of 2020
They do not know how to market their product and suck at SEO
The News is Good but...
until they hire someone that knows what the Hell they are doing with SEO and marketing, the sales numbers will continue to be dismal which is reflected in the share price.
I like their effort but Main Street won't make it as a new shopping destination by itself. They cannot compete with Amazon, Ebay, Walmart, Google and Etsy traffic. Plus Pinterest is now getting in the online retail game.
In my opinion, they need to:
1) Add an import products/feed feature where the store owner can upload a spreadsheet with their products or import them from a current WooCommerce, Shopify or BigCommerce shopping cart system. This would allow the Main Street store owner to add hundreds of products and create a new store in minutes.
2) They need to partner with one or more of the large online retailers mentioned above. This would be a huge step. They also need to become an marketplace integration on SellBrite.
There are other issues such as marketing and creating awareness as no one knows of Main St Marketplace. The name itself is an issue as there are more than a dozen Main St Marketplaces.
Would be more interested to know if progress is being made in Boston and what exactly that game plan is.
Yesterday's 8K
----------------------------------------------------
6.5 Voting Agreement. Each Holder agrees, separately and not jointly, to vote at the Company’s next
meeting of stockholders all of such Holder’s shares of Common Stock it beneficially owns on and after the Closing Date, including but not
limited to the Shares, in respect to the proposal to approve a reverse stock split of all outstanding shares of Common Stock, at a ratio to be
determined by the Board of Directors. This covenant does not in any way restrict the Holder from disposing or selling any shares, including
the Shares, directly or indirectly, obligate the Holder to hold a minimum number of shares of Common Stock, prior to such next meeting of
the stockholders, or obligate the Holder to vote in any particular manner regarding such proposal.
---------------------------------------------------
Do Yourself a Favor...
BAIL OUT! Take a loss and move on from this SCAM.
I finally bailed two days ago at $.014
Took a $450 loss but that's better than losing $2K.
Today's PR is the same carrot dangling as the past dozen.
More "PLAN TO's" and now taking "Pre-Orders". Nothing exist! They string you along with plans and designs.
Take a look at ADOMani
Dominion Voting Software Will Be Gone
Would be nice to see KlickZie’s PATENTED trusted digital files become part of whatever voting system is next.
California is losing residents and businesses by the thousands. Taxes are way too high!
https://www.hoover.org/research/california-businesses-leave-state-thousands
The ONLY Good Thing to Happen in California
Proposition 14 to fund state stem cell research approved by California voters
https://www.latimes.com/california/story/2020-11-12/prop-14-stem-cell-research-final-results
Same here. This is starting to rot.
Smells like a typical OTC stock
Where is the update on Boston U??
That is exactly why they use their string along keywords in this scam
"ALYI PLANS TO"
"WE ANTICIPATE"
There is nothing here but they can keep pumping fluffed PR's and hook more suckers like myself when I was off my game and didn't do thorough DD.
I hope they land a few more suckers soon so the share price bumps up a bit and I can bail out with a smaller loss. Looking at Adomani
On Board with ADOM
Took a small starter position today. Looks like a good company for the growing future of medium to heavy-duty commercial electric vehicles market.
FYI: My 5000 share buy is not in the BUY column.
Today's PR (Condensed Version)
Alternet Systems announced a meeting with iQSTEL,. The two companies "announced" a letter of intent (LOI) agreement to codevelop two-way device communication solutions specific to the EV operating environment.
Notice it states "announced", not SIGNED
10-Q Out
Vivos Inc. 10-Q $RDGL
https://www.otcmarkets.com/filing/html?id=14474183&guid=xDNeUqzm3kPR83h
These Idiots Just Cannot Help Themselves
There is no point in this. I swear they do it just to tease us.
ALYI EXPECTS Very Active Electric Mobility Ecosystem Agenda In November And December
DALLAS, Oct. 30, 2020 /PRNewswire/ -- Alternet Systems, Inc. (USOTC: ALYI) followed up today on a comprehensive management update released earlier this week to preview anticipated milestones expected in the course of November and December.
The update released earlier this week highlighted the company's latest progress with the electric vehicle race to be the anchor event in an annual electric mobility symposium; the introduction of an additional new electric motorcycle design path, and the status of RevoltTOKEN's pending Initial Cryptocurrency Offering (ICO).
In conjunction with the update released earlier this week and as noted in the update, ALYI management has pending announcements expected over the next two weeks on the electric vehicle race, the new electric motorcycle design path and the ICO. The coming announcements over the next two weeks will set the pace for ALYI's overall tempo for the balance of 2020.